Aurora Cannabis Inc. (TSE:ACB – Get Rating)'s share price reached a new 52-week low during trading on Friday after Stifel Nicolaus lowered their price target on the stock from C$2.15 to C$1.75. The stock traded as low as C$1.52 and last traded at C$1.57, with a volume of 1403886 shares. The stock had previously closed at C$1.66.
Several other research firms also recently weighed in on ACB. ATB Capital upgraded Aurora Cannabis from an "underperform" rating to a "sector perform" rating and upped their price target for the stock from C$3.00 to C$4.00 in a research note on Thursday. Cowen increased their price target on shares of Aurora Cannabis from C$1.85 to C$2.00 in a report on Tuesday, July 19th. Piper Sandler decreased their price target on shares of Aurora Cannabis to C$4.00 and set a "neutral" rating for the company in a research note on Wednesday. Cowen lifted their price objective on shares of Aurora Cannabis from C$1.85 to C$2.00 in a report on Tuesday, July 19th. Finally, CIBC dropped their price objective on shares of Aurora Cannabis from C$3.75 to C$2.50 and set a "neutral" rating on the stock in a report on Monday. Ten analysts have rated the stock with a hold rating, According to data from MarketBeat.com, Aurora Cannabis currently has a consensus rating of "Hold" and an average price target of C$3.53.
Get Aurora Cannabis alerts:Aurora Cannabis Trading Down 3.6 %
The company has a current ratio of 5.85, a quick ratio of 3.95 and a debt-to-equity ratio of 35.61. The business has a 50 day moving average price of C$1.97 and a 200 day moving average price of C$2.84. The company has a market capitalization of C$476.44 million and a P/E ratio of -0.27.
Aurora Cannabis Company Profile
(Get Rating)Aurora Cannabis Inc produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients.
Featured Articles
- Why Does Tesla Stock Remain Resilient?
- 2 Semiconductor Stocks To Watch For Reversals
- Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
- Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
- Will Crowdstrike Get A Boost From Increased EPS Guidance?
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.